PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Recognises Rhein Chemie for its Exceptional Product Innovation in Bioplastic Additives Market - Superior performance characteristics of BioAdimide™ set to expand application horizon for Bioplastics - RheinChemie.com / BioAdimide.com / LANXESS.com
Frost & Sullivan Recognises Rhein Chemie for its Exceptional Product Innovation in Bioplastic Additives Market

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/10/11 - Superior performance characteristics of BioAdimide™ set to expand application horizon for Bioplastics - RheinChemie.com / BioAdimide.com / LANXESS.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The 2011 Frost & Sullivan Global New Product Innovation Award in the Bioplastic Additives Market is presented to Rhein Chemie for BioAdimide™. This innovative additive product has been specifically formulated for bioplastics and is poised to widen the applications of poly lactic acid (PLA) plastic.

"The inherent deficiencies of bioplastics, such as poor processing characteristics and insufficient physical and mechanical properties, have limited the opportunities for their expansion into advanced application arenas," notes Frost & Sullivan Industry Analyst Deepan Kannan. "However, with the incorporation of BioAdimide™ as an additive in the bioplastic formulation, these challenges can be avoided, facilitating their use in high end applications."

PLA is a biopolymer that typically lacks hydrolytic stability and has low melt stability. BioAdimide™, when added to the polymer formulation, imparts hydrolytic and melt stability to PLA, thereby enhancing the processability and durability of the end product.

"Upon addition of BioAdimide™, the melt stability of PLA is projected to increase by 20 to 30 per cent," explains Kannan. "The improvement in hydrolytic stability is also expected to improve the durability of the product, almost three to seven times."

Another significant advantage of using BioAdimide™ is that it enables the blending of PLA with high temperature plastics. This opens up a new array of applications for the polymer.

Moreover, the addition of BioAdimide™ (BioAdimide.com) offers scope for the incorporation of higher levels of regrind materials in its formulation. The amount of regrind material added to the virgin resin can be increased to as much as 40 per cent.

"In case of PLA blends with synthetic plastics, this innovative product also offers an opportunity to increase the biorenewable content of the final plastic as it eliminates some of the inherent deficiencies of the bioplastic," says Kannan. "The increase in renewable content in the final plastic leads to significant reduction in the carbon footprint, boosting overall sustainability."

Apart from enhancing processability, BioAdimide™ also enables efficient processing of bioplastics at lower temperatures, thereby reducing the need for high temperature processing. Despite its premium price, it holds tremendous customer appeal as it renders superior performance benefits to the bioplastic.

The entire value chain of bioplastic producers, including resin manufacturers, compounders and plastic processors/converters, will be a target base for BioAdimide™. Through this product, Rhein Chemie is aiming to expand the horizons of bioplastics to third generation applications, including automotive, consumer electronics and other technical fields that demand durability and high performance characteristics.

The New Product Innovation Award is presented to the company that has excelled in the following criteria: for innovative element of the product, for leveraging leading edge technologies in product, for value added features/benefits, for increased customer ROI (small change) and for customer acquisition/penetration potential.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

"We are very pleased that Frost & Sullivan elected us as from many competitors. They realized the innovation of the new product line BioAdimide™ which enables the production of renewable, bio-based polymers for durable applications with a lower environmental impact". That's a real innovation for the third generation of bioplastics, emphasized Fei Tan, Head of Global Business Development Engineering Plastics Division

About Engineering Plastics Division

Additives from the Engineering Plastics Division are used to protect polymers from hydrolysis and the premature aging associated with this process. The company's product portfolio also includes catalysts and activators for the manufacture of cast nylon and modifiers that improve the impact resistance of polyamides. In addition, highly developed catalysts, crosslinking agents and stabilizers from Rhein Chemie are used in the manufacture of flexible and rigid polyurethane foams.

About Rhein Chemie Rheinau GmbH / Rhein Chemie

Rhein Chemie develops (rheinchemie.com / bioadimide.com), produces and sells additives, specialty chemicals and service products for the rubber, lubricant and plastics industries. Rhein Chemie has approximately 1,000 employees worldwide. The company is headquartered in Mannheim, Germany and has production facilities in Europe, Asia and North and South America. Rhein Chemie is a wholly owned subsidiary of the specialty chemicals group LANXESS, Leverkusen, Germany.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

Manuela Schroeder | Corporate /Market Communications Rhein Chemie | manuela.schroeder[.]rheinchemie.com | P: +49 (0) 621-8907-429.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognises Rhein Chemie for its Exceptional Product Innovation in Bioplastic Additives Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | LANXESS Press Room
Publisher Contact: Emily Bailey 
+44(0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)